APP and Alzheimer disease: Importantly, the use of these transgenic APP models in previous studies led to somewhat biased results, as particularly the insertion of the APPswe mutations at the β-secretase site resulted in the almost exclusive generation of Aβ1-x, whereas Aβ2-x and other N-terminal truncated Aβ peptides are absent [21], thus not properly reflecting the situation in human AD.